SCHEMBL13304500

SCHEMBL13304500

CCOC(=O)c1cnc(N2CCC(Cn3ccn(-c4ccc(Oc5ccccc5)cc4)c3=O)CC2)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.39
ACACB O00763 1/20 0.38
OGA O60502 1/20 0.38
HTT P42858 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
HDAC6 Q9UBN7 3/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
SLC6A7 Q99884 1/20 0.37
APP P05067 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
USP2 O75604 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304505 0.92 HDAC6 (0.40) MEN1KMT2AMAPTACACBOGA
SCHEMBL13304501 0.90 HTT (0.41) MEN1KMT2AHTTRXFP1HDAC6
SCHEMBL13304510 0.88 OGA (0.40) MEN1KMT2AMAPTACACBOGA
SCHEMBL13304475 0.86 HDAC6 (0.51) HTTRXFP1HDAC6HDAC1HDAC3
SCHEMBL13304524 0.82 HDAC6 (0.43) MAPTACACBOGAHTTHDAC6
SCHEMBL13304506 0.80 HDAC6 (0.44) HDAC6ALDH1A1SLC6A7POLBHDAC1
SCHEMBL13304502 0.79 HDAC6 (0.38) HTTRXFP1HDAC6HDAC1HDAC3
SCHEMBL13304597 0.78 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL13304593 0.78 KDM1A (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL13304518 0.77 HDAC6 (0.39) MEN1KMT2AACACBOGAHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2010-06-24 US disclosed
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC2, HDAC3 MEN1 2475/4885KMT2A 71/4885MAPT 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.